Insider Transactions in Q1 2021 at Orthopediatrics Corp (KIDS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
(Reynolds) Marie C Infante Director |
SELL
Open market or private sale
|
Direct |
700
-15.21%
|
$31,500
$45.78 P/Share
|
|
Mar 15
2021
|
Harold Ruf Director |
BUY
Other acquisition or disposition
|
Indirect |
2,400
+50.0%
|
-
|
|
Mar 15
2021
|
Harold Ruf Director |
SELL
Other acquisition or disposition
|
Indirect |
2,400
-12.71%
|
-
|
|
Mar 15
2021
|
Harold Ruf Director |
BUY
Open market or private purchase
|
Indirect |
2,880
+13.42%
|
$132,480
$46.98 P/Share
|
|
Mar 15
2021
|
David R Pelizzon Director |
BUY
Open market or private purchase
|
Direct |
3,700
+15.04%
|
$170,200
$46.5 P/Share
|
|
Mar 02
2021
|
David R Bailey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,119
+6.94%
|
-
|
|
Mar 02
2021
|
Mark C Throdahl Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,277
+3.36%
|
-
|
|
Mar 02
2021
|
Gregory A Odle President of Scoliosis |
BUY
Grant, award, or other acquisition
|
Direct |
5,929
+7.79%
|
-
|
|
Mar 02
2021
|
Fred Hite COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,119
+9.14%
|
-
|
|
Mar 02
2021
|
Daniel J Gerritzen General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
5,756
+14.21%
|
-
|
|
Mar 01
2021
|
David R Bailey President and CEO |
SELL
Open market or private sale
|
Direct |
4,769
-5.12%
|
$262,295
$55.84 P/Share
|
|
Mar 01
2021
|
Mark C Throdahl Director |
SELL
Open market or private sale
|
Direct |
5,097
-3.36%
|
$280,335
$55.88 P/Share
|
|
Mar 01
2021
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
8,193
-11.3%
|
$450,615
$55.88 P/Share
|
|
Mar 01
2021
|
Fred Hite COO and CFO |
SELL
Open market or private sale
|
Direct |
4,310
-6.34%
|
$237,050
$55.87 P/Share
|
|
Mar 01
2021
|
Daniel J Gerritzen General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,633
-8.32%
|
$144,815
$55.85 P/Share
|
|
Feb 25
2021
|
Bernie B Berry Iii Director |
SELL
Open market or private sale
|
Direct |
699
-2.11%
|
$39,843
$57.0 P/Share
|
|
Feb 22
2021
|
Bernie B Berry Iii Director |
SELL
Open market or private sale
|
Direct |
1,600
-4.6%
|
$91,200
$57.09 P/Share
|
|
Feb 19
2021
|
Bernie B Berry Iii Director |
SELL
Open market or private sale
|
Direct |
1,701
-4.66%
|
$96,957
$57.16 P/Share
|
|
Feb 19
2021
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
3,750
-4.92%
|
$210,000
$56.5 P/Share
|
|
Feb 18
2021
|
Bernie B Berry Iii Director |
SELL
Open market or private sale
|
Direct |
4,000
-9.88%
|
$216,000
$54.07 P/Share
|
|
Feb 05
2021
|
Mark C Throdahl Director |
SELL
Open market or private sale
|
Direct |
12,651
-7.7%
|
$632,550
$50.34 P/Share
|
|
Feb 04
2021
|
Mark C Throdahl Director |
SELL
Open market or private sale
|
Direct |
7,349
-4.28%
|
$367,450
$50.18 P/Share
|
|
Jan 27
2021
|
Bernie B Berry Iii Director |
SELL
Open market or private sale
|
Direct |
3,136
-7.19%
|
$159,936
$51.73 P/Share
|
|
Jan 27
2021
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
3,750
-4.69%
|
$191,250
$51.63 P/Share
|